Sudeep Pharma IPO Soars on Debut, Investors Gain 24% on First Day
Mumbai: Pharmaceutical company Sudeep Pharma made a spectacular debut on the stock market on Friday, rewarding its IPO investors with handsome gains. Shares listed at a significant premium, reflecting strong investor enthusiasm.
On the BSE, the stock opened at ₹733.95 per share against its issue price of ₹593, marking a 23.77% gain. Meanwhile, on the NSE, it started at ₹730, up 23.10% from the issue price. This listing largely met expectations set by the grey market premium (GMP), which was around 20% prior to listing.
Strong Investor ResponseSudeep Pharma’s IPO witnessed overwhelming demand. Open for subscription from 21 to 25 November, the IPO was subscribed 93.71 times overall. Qualified Institutional Buyers (QIBs) bid 213.08 times, marking one of the most aggressively sought entr...









